The aim of the present study was to investigate whether glutamine pretreatment improves intestinal injury in rats with endotoxemia by its heme oxygenase-1 induction in the lower intestinal tract.
D espite recent progress in antibiotic and critical care therapy, sepsis remains a serious cause of morbidity and mortality, especially in intensive care units (1) . The gastrointestinal tract plays an important role in the pathogenesis of sepsis both as a contributor to immune activation via bacterial translocation and as a site of end-organ injury (2, 3) . Treatment of animals with lipopolysaccharide (LPS), a component of the cell wall of Gram-negative bacteria, elicits systemic inflammation and symptoms similar to those observed in Gram-negative bacterial sepsis (4) . In LPS-induced tissue injury, reactive oxygen species are thought to be involved in its pathogenesis (5) . However, this aspect has not been pursued in the strategic improvement of treatment for septic intestinal injury (6) .
Heme oxygenase (HO)-1 is the ratelimiting enzyme in heme catabolism (7) and is also known as the heat shock protein 32 (8) as well as an acute phase reactant (9) . HO-1 is induced not only by heme, its substrate (7) , but also by various oxidative stresses and cytokines (10, 11) . HO-1 induction has been considered to protect cells against oxidative injuries (10, 11) . We also have demonstrated that endogenously induced HO-1 is involved in the fundamental protection of mucosal epithelial cells of the rat intestine from oxidative damages that occur in sepsis (12) .
Glutamine (Gln), traditionally considered a nonessential amino acid, is now also recognized as a conditionally essential nutrient during serious injury or illness (13) . Gln has been shown to be beneficial in the prevention of infectious morbidity and mortality in seriously ill patients (14, 15) , in part due to its ability to maintain the integrity of intestinal mucosal epithelium (16, 17) . However, the mechanism of protection by Gln remains largely unclear (18) . In this study, we examined the effect of Gln administration on HO-1 expression in various regions of the intestine and on intestinal tissue injury in a rat model of sepsis, which was produced by intraperitoneal LPS administration. We also examined the influence of Gln on LPS-induced mortality. We report here that Gln treatment induced HO-1 highly specifically in the ileum and the colon, and the priming of HO-1 in these lower intestinal tissues prevented LPS-mediated endotoxemic tissue injury. Furthermore, Gln significantly reduced LPS-induced mortality. In contrast, inhibition of the Gln-mediated increase in HO activity by tin mesoporphyrin (SnMP), a specific competitive inhibitor (19) , entirely abolished the beneficial effect of Gln. The protective role of Gln is thus due to its site-specific HO-1inducing activity in the lower intestinal tract, which leads to the attenuation of tissue inflammation, the suppression of apoptosis, and the reduction of mortality.
MATERIALS AND METHODS
Animals. Animal experiments were approved by the Animal Care Committee of Okayama University Medical School; care and handling of the animals were in accordance with National Institutes of Health guidelines. Male Sprague-Dawley rats, weighing 220 -250 g, were purchased from Charles River (Yokohama, Japan). They were housed in a temperature-controlled (25°C) room with alternating 12-hr/12-hr light/dark cycles and were allowed free access to water and chow diet until the start of experiments.
Experimental Protocol. Rats were anesthetized with pentobarbital (40 mg/kg of body weight, intraperitoneally) and injected intravenously via a tail vein with Gln (Invitrogen, Carlsbad, CA; 0.75 g/kg), which had been prepared as a 3% solution dissolved in lactated Ringer's solution (LR) followed by filtration with a 0.45-m filter (Millipore, Billerica, MA) immediately before use (20) , by using a syringe pump at a rate of 0.5 mL/min (per Animal Care Committee recommendation) (Gln group; n ϭ 33). Thus, 5.5-6.25 mL of Gln solution (25 mL/kg) was administered over 11-12.5 mins per rat depending on the weight of the animal. Control rats received 25 mL/kg of LR (LR group; n ϭ 18). Some rats were also administered SnMP (1 mol/kg) at 8 hrs after Gln treatment (Gln/SnMP group; n ϭ 6). SnMP had been dissolved in a small volume of 0.1 N NaOH solution, and then pH was adjusted to 7.6 with 0.01 M sodium phosphate buffer (12) .
Endotoxemia was induced by LPS treatment of rats as described previously (12, 21) . Animals were injected intraperitoneally with LPS (Escherichia coli, 0128:B8, Sigma Chemical, St. Louis, MO; 10 mg/kg) dissolved in 1 mL of sterile physiologic saline. Control rats received the same volume of sterile physio-Figure 1. Effect of glutamine (Gln) administration on heme oxygenase (HO)-1 gene expression in various regions of the intestine. Rats were killed at 0, 1, 2, 3, 6, 9, and 12 hrs after intravenous injection of Gln (0.75 g/kg). Intestines were excised and dissected into four segments-duodenum, jejunum, ileum, and colon-for Northern blot analysis as described in Materials and Methods. A, 20 g of total RNA was subjected to Northern blot analysis. Shown are the autoradiographic signals of RNA blot hybridized with [␣- 32 logic saline (control group n ϭ 21). After injection, animals were returned to cages and allowed free access to food and water. LPS animals were divided into the following three groups: pretreatment with Gln (0.75 g/kg, intravenously) 9 hrs before LPS treatment (Gln/ LPS group; n ϭ 21), pretreatment with LR 9 hrs before LPS treatment (LR/LPS group, n ϭ 21), and pretreatment with Gln followed by SnMP (1 mol/kg) administration before LPS treatment (Gln/SnMP/LPS group, n ϭ 21). SnMP was administered intravenously via tail vein 1 hr before LPS treatment. Some rats were administered SnMP alone as SnMP controls (SnMP group, n ϭ 21). Under light anesthesia with ethyl ether, animals were killed by decapitation (0 -12 hrs); the entire intestine was excised and then dissected into duodenum, jejunum, ileum, and colon, as described previously (12, 22) . After quick and gentle rinsing in physiologic saline, tissue samples were snap-frozen in liquid nitrogen and stored at Ϫ80°C until used for RNA preparation. For determination of HO activity, intestines were first perfused in situ with physiologic saline until the venous effluent became clear and then removed for preparation of microsomes.
An additional group of rats were injected intraperitoneally with 20 mg/kg LPS for the study of mortality. These animals were also divided into the Gln/LPS, LR/LPS, and Gln/ SnMP/LPS groups (n ϭ 12 for each group), and their survival was assessed every 3 hrs through 24 hrs.
Complementary DNA (cDNA) Probes. Template cDNA for HO-1 was rat pRHO-1 (23) . Template cDNA for tumor necrosis factor (TNF)-␣ was rat TNF-␣ cDNA corresponding to 27-668 base pairs (24) , which was cloned from LPS-treated rat ileum library and constructed in pGEM-T Vector (Promega, Madison, WI). Template cDNA for Bcl-2 was rat Bcl-2 cDNA corresponding to 242-785 base pairs (25) , which was cloned from fetal rat brain library and also constructed in pGEM-T Vector. All probes used for Northern blot analysis were [␣-32 P]dCTP (NEN Life Science Products, Boston, MA) labeled cDNA probes prepared according to the manufacturer's instructions by using a random primer DNA labeling system (Amersham Pharmacia Biotech, Piscataway, NJ).
RNA Isolation and Northern Blot
Analysis. Total RNA was isolated from the rat tissues using Tri-Reagent (Sigma Chemical) according to the manufacturer's protocol. Northern blotting was performed as described previously (12) . Twenty micrograms of total RNA was subjected to electrophoresis in a 1.2% agarose gel containing 6.5% formaldehyde. After blotting on a sheet of Bio-Rad Zeta-Probe membrane (Bio-Rad Laboratories, Richmond, CA), RNA samples were hybridized with [␣-32 P]dCTP-labeled cDNA probe followed by washing under stringent conditions. The membrane was exposed to a sheet of Fuji Medical radiograph film with an intensifying screen at Ϫ70°C, and autoradiographs and 18S ribosomal RNA were quantified by using an image scanner (GelPrint 2000i, Genomic Solutions, Ann Arbor, MI) and a computerized image analysis software (Basic Quantifier version 3.0, Genomic Solutions). Relative amounts of radiolabeled cDNA that hybridized to the blots were normalized to 18S ribosomal RNA levels for loading errors.
Histologic Study. Intestinal tissue was fixed in 10% neutral buffered formalin, embedded in paraffin, and sectioned at 4to 6-m thickness. After deparaffinization and dehydration, the sections were stained with hematoxylin and eosin for microscopic examination. Slides were scored for histologic changes in a blinded fashion by using the grading system of Adams and Tepperman (26) . For immu- nohistochemical changes, endogenous peroxidase activity was first blocked by 3% hydrogen peroxide. Slides were also incubated at 37°C for 3 hrs with rabbit polyclonal antirat HO-1 (StressGen Biotechnologies, Victoria, BC, Canada). The percentage of immunoreactive cells in the lamina propria was recorded in Ն500 cells on each slide (27) . Tissue sections were also incubated at 37°C for 3 hrs with a polyclonal antibody (Cell Signaling, Beverly, MA) that specifically recognizes the large fragment (17/19 kD) of activated, but not full-length, caspase-3 (28) . The antigen-antibody reaction was detected by using an antirabbit secondary antibody and an avidin-biotin immunoperoxidase staining kit (DAKO, Carpenter, CA). The positive reaction was visualized as brown stain following treatment with 3, 3'-diaminobenzidine. Normal rabbit serum was used as control for nonspecific staining. Sections were counterstained with hematoxylin. The number of activated caspase-3 positive cells was counted in five nonconsecutive sections per rat at a magnification of ϫ400.
Intestinal HO Activity. Tissues were homogenized in four volumes of 0.1 M potassium phosphate buffer (pH 7.4) containing 0.25 M sucrose and a protease inhibitor (Complete, Boehringer Mannheim GmbH, Mannheim, Germany) and centrifuged at 11,000 ϫ g for 20 mins at 4°C. The supernatant was collected and centrifuged at 105,000 ϫ g for 60 mins at 4°C. After centrifugation, the microsomal pellet was collected and resuspended in 1.15% KCl-0.1 M potassium phosphate buffer (pH 7.4) and used to measure HO activity as described previously (29) . The cytosolic fraction prepared from the liver of adult untreated rats served as a source of biliverdin reductase in the HO assay. HO activity was expressed as picomoles of bilirubin formed per milligram of protein per 60 mins. Protein concentration was determined by the method of Lowry et al. (30) .
Statistical Analysis. Statistical evaluation was performed with unpaired Student's t-test or, when multiple comparisons were made, with analysis of variance followed by Scheffé's F test. Data are presented as mean Ϯ SEM. The product limit (Kaplan-Meier) estimate of the cumulative survival was assessed with log-rank test for survival data. Calculations were performed using Statview software (Abacus Concepts, Berkeley, CA). Differences were considered as significant at p Ͻ .05.
RESULTS

Effect of Gln Administration on HO-1 Messenger RNA (mRNA) Expression in
Various Regions of the Intestine. HO-1 mRNA level was markedly increased following Gln administration in the lower intestinal tract such as the ileum and the colon (Fig. 1 ). For example, the HO-1 mRNA level in the ileum markedly increased and reached a maximum ‫-2.4ف(‬ fold the control level) at 3 hrs after Gln administration, maintained its level till 6 hrs, and then rapidly declined to a near basal level by 9 hrs. In the colon, its level markedly increased at 2 hrs after the treatment, reached a maximum at 3 hrs (‫-1.5ف‬fold the control level), and then rapidly decreased to the basal level by 6 hrs (Fig. 1) . In contrast, HO-1 mRNA levels in the duodenum and the jejunum were virtually unaffected by Gln treatment ( Fig. 1 ). We also examined the effect of administration of 1.4% saline solution (478 mOsm/L) itself, an osmolarity of the Gln solution on HO-1 mRNA levels. HO-1 mRNA levels in the ileum and the colon of the 1.4% saline-treated animals were essentially identical to those of LR control animals ( Fig. 1B, insets) , indicating that HO-1 mRNA was induced by Gln but not by the osmolarity of the solution used.
Distribution of HO-1 Protein in the Intestine Following Gln Administration. In LR control animals, HO-1 protein was barely detectable in the ileum (Fig. 2C ) and the colon (Fig. 2D ) as well as in the duodenum and the jejunum (data not shown), 9 hrs after Gln treatment. Consistent with enhanced HO-1 gene expression in the lower intestine, positive staining of HO-1 protein was observed in the ileum (Fig. 2 , E-H) and in the colon ( Fig.  2I and 2J) in Gln animals. Strong signals of HO-1 were also observed in the mucosal epithelial cells in these tissues (Fig. 2 , E-J). HO-1 protein-positive cells were also observed in mononuclear cells in the lamina propria ( Fig. 2F, 2H , and 2J). The percentage of immunoreactive lamina propria cells in Gln animals was significantly higher than that in LR control animals ( Table 1 ). In contrast to the ileum and the colon, HO-1 protein expression in the duodenum ( Fig. 2A ) and in the jejunum (Fig. 2B ) was hardly affected following Gln treatment. Sections from Gln animals incubated with nonimmune rabbit serum showed no signals (data not shown).
Effect of Gln Treatment on HO Activity. HO activity in the lower intestine was also examined 9 hrs after Gln or LR treatment. Intestinal HO activity increased by ‫-01ف‬fold compared with LR control (Fig.  3) . In contrast, administration of SnMP, a specific competitive inhibitor of HO, to Gln animals 1 hr before LPS treatment markedly decreased its activity almost to the same level as LR control animals (Fig.  3) . These results indicate that Gln treatment markedly and specifically increased HO activity in the lower intestine, and that administration of SnMP completely inhibited the Gln-mediated increase in HO activity.
Effect of Gln Pretreatment on Histologic Damage and TNF-␣ Gene Expression. The extent of tissue injury and inflammation was also assessed by histologic analysis and TNF-␣ gene expression. Sections of the intestine excised from untreated control animals (control group) revealed a normal histologic appearance (Fig. 4) . In contrast, extensive mucosal damage such as hemorrhagic damage in the mid-to lower mucosa and mucosal ulceration were observed at 12 hrs after LPS treatment (LR/LPS, Fig. 4 ). In contrast, Gln/LPS treatment showed only mild mucosal changes such as edema of the villi with epithelial lifting and mild vasocongestion (Fig. 4) . These findings demonstrated that Gln pretreatment markedly improved LPS-induced tissue injury. TNF-␣ mRNA expression in the ileum and colon was barely detectable in control animals (control group, Fig.  5 ). TNF-␣ mRNA level significantly increased in the lower intestine 3 hrs after LPS treatment (Fig. 5 ). In contrast, TNF-␣ mRNA level markedly decreased in Gln/LPS animals ‫%53ف(‬ and ‫%54ف‬ of LR/LPS animals in the ileum and the colon, respectively, Fig. 5 ). Thus, LPSinduced tissue inflammation was markedly attenuated by Gln pretreatment. We also administered SnMP, a specific competitive inhibitor of HO, intravenously 1 hr before LPS treatment to Gln-pretreated animals. SnMP/Gln/LPS animals showed an increase in histologic damage score similar to LPS-treatment alone (Fig. 4 ). TNF-␣ mRNA level was also elevated and reached a level similar to that in LR/LPS animals ( Fig. 5 ). SnMP treatment by itself in control animals (SnMP group) had no effect on either TNF-␣ Figure 4 . Effect of glutamine (Gln) pretreatment on histologic damage in the lower intestine of lipopolysaccharide (LPS) rats. Rats were administered Gln or lactated Ringer's solution (LR) intravenously 9 hrs before intraperitoneal injection of LPS (10 mg/kg). Tin mesoporphyrin (SnMP; 1 mol/kg) was administered to rats intravenously 1 hr before LPS treatment. Twelve hours after the LPS injection, the ileum and the colon were removed for histologic study as described in Materials and Methods. A damage score of 1 indicates epithelial cell damage; 2 indicates glandular disruption, vasocongestion, or edema in the upper mucosa; 3 indicates hemorrhagic damage in the mid-to lower mucosa; 4 indicates deep necrosis and ulceration. Each section was evaluated on a cumulative basis to obtain the histologic index of injuries with a maximum score of 10. A, histologic damage score of intestinal mucosal sections. Control, saline control; SnMP, SnMP treatment alone; LR/LPS; LPS with LR pretreatment; Gln/LPS; LPS with Gln pretreatment; Gln/SnMP/LPS, LPS with Gln pretreatment followed by SnMP administration, lanes 1, 2, 3, 4, and 5, ileum; lanes 6, 7, 8, 9, and 10 gene expression or histologic changes in the ileum and the colon ( Figs. 4 and 5) . Thus, SnMP administration in Glnpretreated animals essentially abolished the Gln-mediated increase in HO activity and resulted in the loss of the protective effect afforded by Gln. All these findings corroborate the hypothesis that Glninduced HO activity contributes to the improvement of LPS-induced mucosal injury and inflammation in the lower intestine.
Effect of Gln Pretreatment on Apoptosis. Whereas Bcl-2 mRNA, an antiapoptotic gene (31) , was expressed in control animals (control group), its level markedly decreased in the ileum ‫%04ف(‬ of the control) and the colon ‫%53ف(‬ of the control) 9 hrs after LPS treatment (Fig. 6 ). In contrast, Gln/LPS treatment elevated Bcl-2 mRNA expression and restored it to a level almost the same as in control animals in both the ileum and the colon (Fig. 6 ). Whereas activated caspase-3-positive cells, a specific and reliable marker for apoptosis (28) , were only mar-ginally detectable in control animals (control group), their number markedly increased in the ileum and the colon following LPS treatment. The increase of activated caspase-3-positive cells was observed exclusively in the mucosal epithelial cells (Fig. 7) . In contrast, Gln/LPS animals showed a marked decrease in the number of activated caspase-3-positive cells (Fig. 7) . These findings demonstrate that Gln pretreatment markedly attenuates LPS-induced apoptosis of intestinal epithelial cells. To examine whether the anti-apoptotic effect of Gln is attributable to its ability to increase HO activity, Gln/ LPS animals were additionally treated with SnMP (Gln/SnMP/LPS group). Gln/ SnMP/LPS animals not only showed suppression of Bcl-2 gene expression almost to the same level as LPS animals ( Fig. 6 ) but also increased the number of activated caspase-3-positive cells to a level similar to that of LR/LPS treatment (Fig.  7) . SnMP treatment by itself in control animals (SnMP group) had no effect either on Bcl-2 gene expression or on the number of activated caspase-3-positive cells in the ileum and the colon (Figs. 6  and 7) . Thus, SnMP administration ablated the antiapoptotic effect of Gln pretreatment via its specific inhibition of HO activity. All these findings indicate that the antiapoptotic effect of Gln in the lower intestine is conferred by its ability to increase HO activity.
Effect of Gln Treatment on the Survival of LPS Rats. The effect of Gln treatment on the survival of animals was then examined. As 10 mg/kg of LPS was not sufficient to permit evaluation of survival, 20 mg/kg of LPS was injected into rats intraperitoneally. The survival rate at 24 hrs after LPS treatment was 33% and 92% in LR/LPS and Gln/LPS groups, respectively (p Ͻ .05, n ϭ 12 for each group). In contrast, additional administration of SnMP to Gln/LPS animals 1 hr before LPS administration essentially abolished the beneficial effect of Gln. These results indicate that Gln treatment significantly attenuates LPS-induced 
DISCUSSION
The present study demonstrates that Gln pretreatment significantly improves intestinal tissue injury in a rat model of endotoxemia produced by LPS treatment. Gln exerted the protective effect by its site-specific induction of HO-1 in the mucosal cells in the ileum and the colon and led to the attenuation of tissue inflammation, apoptotic cell death, and mortality. Inhibition of HO activity by administration of SnMP, a specific competitive inhibitor of HO activity (19) , completely abolished the protective effects of Gln. These findings thus add further evidence to the concept that HO-1 plays a fundamental role in the protection of intestinal cells from oxidative injury induced by endotoxemia (11) .
As shown in Figure 1 , HO-1 mRNA expression in the ileum and colon following Gln treatment was much higher than that in the duodenum and the jejunum. This is the first time that HO-1 mRNA expression was found to occur in a sitespecific manner in the intestine. The mechanism of HO-1 induction by Gln remains, however, elusive. Gln treatment has been reported to increase expression of HSP72, whereas inhibition of HSP72 expression with quercetin, an inhibitor of heat shock factor, significantly blunts the Gln-mediated protection, suggesting that Gln-mediated protection against oxidative stress may in part be mediated through the activation of heat shock element (32) . Rat HO-1 also has a heat shock element in its promotor region and is inducible by heat treatment (8) . Thus, it is possible that the Gln-mediated HO-1 induction in the lower intestine might involve the activation of its heat shock element. Acute enteral glutamine infusion has been reported to enhance HO-1 not only in epithelial cells but also in lamina propria cells in the duodenal mucosa in humans (27) . Our findings in this study are also consistent with this report in that marked induction of HO-1 occurred both in epithelial cells and in lamina propria cells (Table 1) . Thus, the important aspect in the Gln-mediated increase in HO-1 is not only its sitespecific induction but also its cell-specific nature in the lower intestine.
We also found that intravenous administration of Gln before LPS treatment improved tissue inflammation in the lower intestine (Fig. 5 ). Consistent with our findings, Wischmeyer et al. (33) reported that intravenous Gln administration reduces the plasma level of proinflammatory cytokine after LPS treatment in rats. Gln-supplemented enteral diet has also been reported to decrease not only interleukin-8, a potent inflammatory cytokine, but also TNF-␣ concentrations in the colonic tissue in trinitrobenzene sulphonic acid-induced colitis in rats (34) . Moreover, clinical trials have demonstrated that Gln supplementation reduces morbidity and mortality in criti- cally ill patients (15) . The greatest effect was observed in patients receiving highdose parenteral Gln (15) . Thus, we employed the intravenous administration of Gln with a relatively high dose (0.75 g/kg) in this study.
Our previous study showed that HO-1 levels were induced in the mucosal epithelial cells in the duodenum and the jejunum following LPS treatment, but not in the ileum and the colon, whereas tissue injury was more marked in the lower intestine than in the upper intestine (12) . Thus, there was a reciprocal relationship between HO-1 induction and tissue injury. Our present study additionally shows that Gln-mediated HO-1 induction in the lower intestine can prevent tissue injury following LPS treatment, and the inhibition of the Glnmediated increase in HO activity by SnMP treatment entirely abolishes the beneficial effect of Gln in this model (Fig.  4) . The new findings in this study thus also substantiate the concept that HO-1 induction is critical in the protection of tissues from oxidative injury (10 -12) . Pharmacologic induction of HO-1 by hemin, a strong specific inducer of HO-1, has also been reported to ameliorate trinitrobenzene sulphonic acid-induced colonic inflammation as evidenced by a decrease in inducible nitric oxide synthase expression (35) .
There is also rapidly growing evidence suggesting an increased apoptotic process in the pathogenesis of sepsis (36, 37) . In support of this hypothesis, Bcl-2 mRNA level, an anti-apoptotic gene (31) , was found to be markedly decreased (Fig.  6 ), and expression of activated caspase-3, an executioner of apoptosis (38) , was markedly increased after LPS treatment (Fig. 7) . In contrast to LPS treatment alone, Bcl-2 mRNA levels in Gln/LPS animals showed a transient increase that returned to the control level at 9 hrs ( Fig.  6 ). LPS-mediated activation of caspase-3 was also decreased by Gln pretreatment but returned to the untreated control level at 9 hrs ( Fig. 7 ), suggesting that Gln pretreatment can also inhibit LPSmediated apoptosis. In support of our hypothesis, it has been reported that Gln specifically protects intestinal epithelial cells against cytokine-induced apoptosis in vitro (39) . As SnMP treatment abolished the anti-apoptotic effect of Gln ( Figs. 6 and 7) , these findings indicate that Gln-induced HO activity is essential in the suppression of LPS-mediated apoptosis.
Most importantly, Gln pretreatment significantly improved the survival of animals following LPS treatment (Fig. 8) . In contrast, administration of SnMP abolished the beneficial effect of Gln. These results clearly indicate that induction of HO activity by Gln is essential for survival of animals from LPS-mediated endotoxemia. They also suggest that Gln treatment may be considered as a new therapeutic modality for the treatment of sepsis in human patients.
The mechanism behind HO-1-mediated protection against LPS-induced tissue injury is not yet entirely clear. However, it is known at least that reactive oxygen species play an important role in LPS-induced tissue injury (5) . HO-1 oxidatively cleaves heme and yields three metabolites: carbon monoxide, iron, and biliverdin IX␣, which is then reduced to bilirubin IX␣ by bilirubin reductase (7) . Although an excess amount of free iron can be cytotoxic if it catalyzes Fenton reaction (40) , iron produced by HO in the cell is largely inactivated by sequestration into ferritin (41) , thus rescuing cells from potential radical injury. In addition, biliverdin IX␣ and bilirubin IX␣ function as potent endogenous anti-oxidants (42) . Bilirubin IX␣ can also be converted to biliverdin IX␣, leading to an accelerated antioxidant cycle that could amplify the antioxidant effect of biliverdin or bilirubin alone (43) . Carbon monoxide is also known to exhibit anti-inflammatory and antiapoptotic properties (44, 45) . Thus, carbon monoxide may also have an important protective function against oxidative tissue injuries. Thus, induction of HO-1 results not only in the reduction of oxidant stress by removing free heme, a potent pro-oxidant (11, 46) , but also in the increase in the level of antioxidants and in the suppression of apoptosis. Our present study fell short of directly demonstrating changes in oxidant levels following LPS or Gln treatment; thus, a further study is necessary to clarify this question. Although it is unclear to what extent each HO-reaction product may exert its role, all these reactions together may provide a fundamental protective milieu for intestinal epithelial cells in coping against LPS-induced tissue injury.
CONCLUSIONS
Our study demonstrated that Gln treatment induced HO-1 specifically in the mucosal cells of the ileum and the colon and protected cells from LPSinduced injury. Gln treatment also attenuated inflammatory response and reduced apoptotic cell death. These findings provide a biochemical basis for the protective role of Gln against LPS-induced intestinal injury and suggest that Gln treatment might be useful as a new therapeutic and preventive modality in severe sepsis in humans. 
